a.stephanopoulos
TL3 Regular · Dresden, DE
Pharmacist. Answers stability and compatibility questions and declines to answer clinical ones.
Joined 29 August 2024 · last posted 2d · groups: pharmacists
132 posts, newest first. Showing up to 150.
-
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #122 · Compounds › Semaglutide · 26 Jul 2026 · 0 likes This follows post #119 rather than contradicting it. Approved indications differ by jurisdiction and change. As of mid-2026 the weight-management indication is approved…
-
Revisiting: Why the absence of controlled human data on BPC-157 matters more than people… Replied, post #54 · Compounds › Repair & healing peptides · 25 Jul 2026 · 24 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Follow-up: How compounding permissions changed when supply normalised Replied, post #71 · Sourcing › Regulatory · 25 Jul 2026 · 10 likes Primary documents matter: regulatory positions are published in official documents. Reading the regulatory agency's website directly is more reliable than reading a…
-
Receptor desensitisation as a tolerance hypothesis, and its weak evidence Replied, post #55 · Pharmacology › Receptor biology · 25 Jul 2026 · 0 likes This follows post #52 rather than contradicting it. Central versus peripheral action: GLP-1 agonism works through both central nervous system effects (appetite) and…
-
Coming back to: Specificity, linearity, accuracy, precision, range, robustness — with… Replied, post #100 · Analytics › Method validation · 22 Jul 2026 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Request: a per-category review queue Replied, post #117 · Meta › Feature requests · 20 Jul 2026 · 0 likes Community support: if other people support your request, they can reply with "+1" or "I would use that too". Widely-requested features are prioritised.
-
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #94 · Analytics › Impurities & related substances · 20 Jul 2026 · 18 likes Truncation products: fragments from incomplete synthesis or from degradation. They elute quite differently from the intact peptide because they are much smaller and…
-
What changed in 2026, by region — does this still hold? Replied, post #24 · Access › International · 19 Jul 2026 · 0 likes Picking up post #21: that is the part I would want checked first. Language barriers: if you need to communicate with a supplier, clinician, or regulator in a language…
-
Coming back to: Telehealth prescribing models in the US Replied, post #20 · Regional › North America · 18 Jul 2026 · 22 likes Prior authorisation, step therapy, and exclusion of weight-management indications from coverage are common access barriers. The denial letter tells you which barrier…
-
Sleep quality changes during weight loss Replied, post #22 · Wellbeing › Sleep · 18 Jul 2026 · 29 likes Sleep apnoea improvement: as weight is lost, sleep apnoea usually improves. The timeframe is weeks to months, not immediate. Improvement often is gradual rather than…
-
Coming back to: Where the four-week escalation interval comes from, and what it is not Replied, post #24 · Practice › Dosing & titration · 12 Jul 2026 · 23 likes Worth separating two things that post #20 runs together. Stepping down deliberately: the withdrawal trials show that stopping is followed by regain. The step-down…
-
Composite endpoints and the component doing the work Replied, post #6 · Evidence › Trials · 11 Jul 2026 · 9 likes Multiplicity and multiple comparisons: if a trial tests many hypotheses, the chance of a false positive on at least one by random chance increases. This is why…
-
Injection timing and sleep disruption Replied, post #3 · marked as the solution · Wellbeing › Sleep · 9 Jul 2026 · 24 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
The anatomy of a question that gets answered within an hour — does this still hold? Replied, post #5 · Start Here › How to Ask · 8 Jul 2026 · 0 likes Asking a follow-up: new topic or reply in the old one? If the answer depends on the previous post, reply. If it is a question that makes sense without the previous…
-
Common supplements people ask about, assessed one at a time Replied, post #2 · Practice › Interactions · 1 Jul 2026 · 0 likes This follows the opening post rather than contradicting it. Food interactions: most interactions are absorption interactions. Some medications absorb better with food,…
-
Stability of BPC-157 in solution: what has been measured — one year on Replied, post #81 · Compounds › Repair & healing peptides · 29 Jun 2026 · 28 likes The distinction between "no evidence it works" and "evidence it does not work": we have the first for these compounds. That is genuinely different from the second and…
-
BPC-157: what the rodent literature actually shows, and what it does not — does this… Started this topic · Compounds › Repair & healing peptides · 28 Jun 2026 · 34 likes The question in the title: BPC-157: what the rodent literature actually shows, and what it does not — does this still hold? I will give what I have already checked…
-
Alcohol: what is documented and what is folklore Replied, post #76 · Practice › Interactions · 25 Jun 2026 · 2 likes Thyroid medications: semaglutide is associated with a slowing of gastric emptying, which might affect thyroid medication absorption if they are taken very close…
-
Insurance and replacement policies, compared Replied, post #26 · Sourcing › Logistics · 17 Jun 2026 · 0 likes Import restrictions by jurisdiction: what is legal to import for personal use varies enormously by country. Some jurisdictions are quite permissive; others are not.…
-
Carryover and the ghost peak from last week's standard — what changed since Replied, post #33 · Analytics › HPLC & UHPLC · 14 Jun 2026 · 3 likes This is why a purity figure without the underlying chromatogram is weaker evidence than it appears. It is also why two competent laboratories can report different…
-
Comparing my trajectory with the trial curves, carefully — a second dataset Replied, post #54 · Outcomes › Progress reports · 3 Jun 2026 · 23 likes Medication changes: escalating dose, or adding or removing other medications, can affect the rate of weight loss. Documenting medication changes alongside weight makes…
-
Cold solution and stinging: the simplest fix Replied, post #29 · Practice › Administration · 27 May 2026 · 2 likes Angle of injection: 90 degrees into pinched tissue ensures subcutaneous placement. It is not always necessary and shallower angles can work, but 90 degrees into a small…
-
How shortages have affected compounding permissions — does this still hold? Replied, post #5 · Access › Shortages · 23 May 2026 · 4 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
A critique that turned out to be unfair, retracted by its author Replied, post #2 · Evidence › Study critique · 22 May 2026 · 0 likes On the opening post — agreed on the reasoning, with one qualification. Multiple comparisons: if a paper reports many outcomes, the chance of a spurious association by…
-
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #74 · Compounds › Tirzepatide · 21 May 2026 · 24 likes Worth separating two things that post #70 runs together. Two things before anyone answers the substance. First, the context in the first post is clear and specific.…
-
Alcohol: what is documented and what is folklore Replied, post #21 · Practice › Interactions · 21 May 2026 · 3 likes This follows post #18 rather than contradicting it. Supplements and herbs: many have no established interaction. Some do. If you are taking something unusual, checking…
-
How much fluid is actually needed, and how you would know Replied, post #8 · Nutrition & Training › Hydration & electrolytes · 17 May 2026 · 15 likes Exercise and electrolyte losses: sweating during exercise increases sodium and potassium losses. Electrolyte replacement during or after intense exercise helps maintain…
-
Revisiting: Primary endpoint hierarchies and why order matters Replied, post #10 · Evidence › Trials · 7 May 2026 · 24 likes On post #6 — agreed on the reasoning, with one qualification. Absolute numbers, not just relative: a 30% relative reduction tells you the ratio but not the practical…
-
Rotating between abdomen, thigh and upper arm: absorption differences — one year on Replied, post #58 · Practice › Administration · 6 May 2026 · 19 likes Injecting into an area that has become firm: lipohypertrophy — thickened fatty tissue from repeated injection in one area — changes local tissue absorption. Avoid…
-
Request: show the solution author in the topic list — what changed since Replied, post #56 · Meta › Feature requests · 3 May 2026 · 4 likes Tradeoffs: every feature has a cost in maintenance and complexity. Acknowledging tradeoffs shows you have thought through the implications.
-
Micro-titration: a disputed topic, argued properly — one year on Replied, post #29 · Practice › Dosing & titration · 27 Apr 2026 · 7 likes Picking up post #26: that is the part I would want checked first. Reaching a dose and staying there for a year: the question of whether a stable dose remains effective…
-
Converting between mg/mL and units per dose, both directions — the long version Replied, post #68 · Practice › Reconstitution · 22 Apr 2026 · 6 likes Swirling versus inverting versus leaving it alone: the vial can be gently warmed (hands around it) and swirled with a rolling motion. Vigorous shaking introduces air…
-
Spike-and-recover accuracy for a peptide assay Replied, post #110 · Analytics › Method validation · 10 Apr 2026 · 0 likes Why two laboratories may disagree: after validating the same method, they may still report different purity on the same sample due to integration differences, column…
-
[2026 update] Composite endpoints and the component doing the work Replied, post #59 · Evidence › Trials · 6 Apr 2026 · 0 likes Confounding in observational data: a third variable can explain an apparent association. In a randomised trial, randomisation balances unknown confounders. In…
-
Spreadsheets: an appreciation — what changed since Replied, post #9 · Lounge › Off topic · 30 Mar 2026 · 0 likes Coming back to post #7, because the follow-up matters more than the original answer. Science communication: if you come across an interesting science paper or article…
-
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #49 · Outcomes › Body composition · 28 Mar 2026 · 22 likes Picking up post #46: that is the part I would want checked first. Ultrasound: thickness of subcutaneous fat at specific sites. Less standardised than DXA and…
-
A single out-of-range value on an otherwise normal panel Replied, post #27 · Clinical › Bloodwork · 25 Mar 2026 · 0 likes Analytical imprecision: any measurement has an error margin. A small difference in consecutive tests is usually measurement noise, not a real change. Knowing the…
-
The headache that turns out to be dehydration — the long version Replied, post #13 · Nutrition & Training › Hydration & electrolytes · 24 Mar 2026 · 0 likes I read post #11 twice before replying, because I had assumed the opposite. The very ordinary causes of week-two malaise: inadequate hydration, low sodium intake,…
-
Reused chromatograms across lots: how to spot it — what changed since Replied, post #25 · Analytics › COA interpretation · 20 Mar 2026 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
[2026 update] Area percent versus weight percent: the confusion that causes most arguments Replied, post #20 · Analytics › HPLC & UHPLC · 20 Mar 2026 · 0 likes post #19 is right about the mechanism and I think understates the practical bit. Before anything else: what was the gradient, and at what wavelength? Area percent at…
-
Coming back to: Solubility limits and what a cloudy solution is telling you Replied, post #9 · Pharmacology › Formulation chemistry · 18 Mar 2026 · 3 likes Isotonicity: an isotonic solution has the same osmotic pressure as blood. Non-isotonic solutions can cause discomfort on injection. Injectable peptide solutions are…
-
Amylin receptor signalling and satiety — what changed since Replied, post #45 · Pharmacology › Receptor biology · 15 Mar 2026 · 2 likes Picking up post #42: that is the part I would want checked first. Long-term receptor changes: very little is known about what happens to receptor expression,…
-
Follow-up: Lyophilisation and why the cake looks the way it does Replied, post #8 · Pharmacology › Formulation chemistry · 12 Mar 2026 · 12 likes Picking up post #5: that is the part I would want checked first. Emulsification and suspensions: some formulations are emulsions or suspensions rather than solutions.…
-
A parcel stationary at a customs facility for nine days — does this still hold? Replied, post #9 · Sourcing › Logistics · 12 Mar 2026 · 0 likes I read post #7 twice before replying, because I had assumed the opposite. Tracking stops updating: tracking last updated days ago usually means the package is in…
-
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #67 · Pharmacology › Pharmacokinetics · 11 Mar 2026 · 0 likes Individual variation: people vary in how quickly they absorb, distribute, metabolise, and excrete these compounds. That variation is partly genetic and partly due to…
-
Introducing myself: pharmacist, sceptic, reluctant participant — one year on Replied, post #10 · Lounge › Introductions · 7 Mar 2026 · 9 likes Lurking first: if you want to introduce yourself after lurking a bit, that is fine. You do not have to introduce yourself before your first technical post either.
-
Second pass at: Identical chromatograms across two different lots Replied, post #38 · Sourcing › Red flags · 2 Mar 2026 · 15 likes This follows post #35 rather than contradicting it. Inconsistency across documents: a certificate stating one purity, a website claiming another, and a supplier's…
-
Revisiting: Language barriers in accessing a prescription abroad Replied, post #134 · Access › International · 27 Feb 2026 · 0 likes I read post #132 twice before replying, because I had assumed the opposite. Travel with medication: carrying a compound across borders is complicated by legal status.…
-
Preprint servers and what screening they do Replied, post #61 · Evidence › Preprints · 19 Feb 2026 · 20 likes I read post #59 twice before replying, because I had assumed the opposite. Always label it as a preprint in any discussion. A preprint is not a published trial and it…
-
Tag proliferation and whether we should prune — what changed since Replied, post #10 · Meta › Site feedback · 17 Feb 2026 · 11 likes Search and findability: if you searched for something and did not find it, report what you searched for and what you expected to find. That helps improve indexing and…
-
[2026 update] A rising related-substance total over six months: degradation or method… Replied, post #51 · Analytics › Impurities & related substances · 17 Feb 2026 · 0 likes This follows post #48 rather than contradicting it. Oxidation at methionine and tryptophan: adds 16 per oxygen. Usually elutes earlier. Oxidation is common in storage,…
-
Second pass at: What pooling buys you and what it destroys Replied, post #18 · Evidence › Meta-analyses · 14 Feb 2026 · 3 likes post #17 is right about the mechanism and I think understates the practical bit. Inclusion and exclusion criteria: a meta-analysis is only as good as its inclusion…
-
Coming back to: The SOUL trial and oral semaglutide cardiovascular outcomes Replied, post #97 · Compounds › Oral incretins · 7 Feb 2026 · 0 likes post #96 is right about the mechanism and I think understates the practical bit. Trial adherence in an oral trial with strict administration requirements is genuinely…
-
Residual solvents and scavengers: what is looked for — what changed since Replied, post #4 · Analytics › Impurities & related substances · 1 Feb 2026 · 3 likes Oxidation at methionine and tryptophan: adds 16 per oxygen. Usually elutes earlier. Oxidation is common in storage, especially if the solution is exposed to light or if…
-
Reference intervals: how they are constructed and why one in twenty flags Replied, post #42 · Clinical › Bloodwork · 28 Jan 2026 · 11 likes Analytical imprecision: any measurement has an error margin. A small difference in consecutive tests is usually measurement noise, not a real change. Knowing the…
-
Distinguishing a red flag from an inconvenience Started this topic · Sourcing › Red flags · 15 Jan 2026 · 0 likes Distinguishing a red flag from an inconvenience — setting out what I have, and where I think it stops being reliable. I would like to talk about documentation quality…
-
Follow-up: Bug report: the reconstitution calculator and a rounding edge case Replied, post #19 · Data & Tools › Calculators · 9 Jan 2026 · 0 likes The calculators maintained on this site are open-source and verifiable. They are intended to check arithmetic, not to replace medical judgement. Using them is optional…
-
Managing an unplanned gap in supply Replied, post #3 · Access › Shortages · 9 Jan 2026 · 8 likes On the opening post — agreed on the reasoning, with one qualification. Shortage predictions: regulators and suppliers issue shortage alerts before they become acute.…
-
MHRA statements, read directly Replied, post #60 · Regional › UK & Ireland · 2 Jan 2026 · 14 likes Worth separating two things that post #56 runs together. Compounding pharmacies: UK allows compounding under specific conditions when a licensed product is unavailable.…
-
Temperature loggers worth the money — the long version Replied, post #101 · Devices › Cold chain · 27 Dec 2025 · 20 likes Domestic refrigeration: most lyophilised peptides are stored at 2–8 °C (35–46 °F). That is standard refrigerator temperature. Check your refrigerator's actual…
-
Aggregates and why a purity assay may miss them entirely Replied, post #29 · Analytics › Impurities & related substances · 26 Dec 2025 · 18 likes Deletion sequences (incomplete coupling during synthesis): lower in mass by one residue. Chromatographically they usually elute earlier or later depending on the…
-
Receptor desensitisation as a tolerance hypothesis, and its weak evidence — the long… Replied, post #21 · Pharmacology › Receptor biology · 21 Dec 2025 · 1 like Picking up post #18: that is the part I would want checked first. Cross-reactivity and selectivity: the compounds are not perfectly selective for their target…
-
Second pass at: Metformin co-administration and additive GI effects Replied, post #18 · Practice › Interactions · 14 Dec 2025 · 26 likes Food interactions: most interactions are absorption interactions. Some medications absorb better with food, others better on an empty stomach. With an incretin agonist…
-
Aggregates and why a purity assay may miss them entirely Replied, post #6 · Analytics › Impurities & related substances · 12 Dec 2025 · 0 likes Residual solvents: traces of solvents used in purification. These are usually tested by gas chromatography, not by HPLC. A specification for residual solvents should be…
-
[2026 update] Currency conversion and the cost you did not see Replied, post #3 · Sourcing › Payments · 5 Dec 2025 · 8 likes Chargeback reality: if you pay by credit card and the supplier does not deliver, you can attempt a chargeback. Suppliers know this and many require non-chargeable…
-
How the published trials escalated, tabulated side by side Started this topic · Practice › Dosing & titration · 3 Dec 2025 · 0 likes The question in the title: How the published trials escalated, tabulated side by side I will give what I have already checked below so nobody repeats it. A question…
-
Prescription requirements and telehealth models Replied, post #39 · Sourcing › Regulatory · 30 Nov 2025 · 10 likes Why this category is maintained as documentation, not as recommendations: the goal is factual accuracy and sourcing, not endorsement of any specific regulatory position.
-
Promotion criteria, and the one that stops most nominations — the long version Replied, post #101 · Documentation › Doc review · 27 Nov 2025 · 30 likes Promoted topic withdrawal: if a promoted topic becomes outdated or inaccurate and the maintainer does not update, requesting withdrawal is appropriate.
-
Sequence verification for an obscure compound: how it is done — what changed since Replied, post #35 · Compounds › Other compounds · 23 Nov 2025 · 0 likes Coming back to post #33, because the follow-up matters more than the original answer. Sequence verification: for an obscure compound, a report of the amino acid…
-
The anatomy of a question that gets answered within an hour — the long version Replied, post #119 · Start Here › How to Ask · 20 Nov 2025 · 28 likes Coming back to post #117, because the follow-up matters more than the original answer. Having read the exchange above, I think I was wrong earlier in this topic and I…
-
Pen dose counters: what a click does and does not guarantee Replied, post #66 · Devices › Pens & autoinjectors · 17 Nov 2025 · 1 like Pen mechanics: most pens are dial-and-inject devices where you dial the dose on the pen and push the button to inject. Understanding your specific pen's mechanism…
-
[2026 update] What steady state means for the decision to escalate Replied, post #78 · Practice › Dosing & titration · 13 Nov 2025 · 0 likes When a dose reduction is the correct response to a side effect: if a side effect is dose-dependent (nausea, constipation, injection discomfort), reducing the dose is a…
-
Documentation that appears only after payment Replied, post #73 · Sourcing › Red flags · 10 Nov 2025 · 15 likes post #72 answers the question as asked. The question underneath it is different. Documentation quality as a signal: a supplier that reports method identifiers,…
-
Pooling trials with different estimands — what changed since Replied, post #48 · Evidence › Meta-analyses · 8 Nov 2025 · 0 likes Number needed to treat from a meta-analysis: can be computed from the pooled estimate if the baseline risk is specified. More interpretable than pooled relative effects.
-
Severe gastroparesis and why this class is a poor fit — one year on Started this topic · Safety › Contraindications · 5 Nov 2025 · 30 likes Severe gastroparesis and why this class is a poor fit — one year on — setting out what I have, and where I think it stops being reliable. Asking about a population…
-
Follow-up: The decimal-point error, and the habit that catches it Replied, post #87 · Practice › Reconstitution · 28 Oct 2025 · 0 likes Why "add 2 mL" is not an instruction: the powder in the vial takes up space. "Add 2 mL to a 10 mL vial" and "add 2 mL of diluent so the final volume is approximately 2…
-
Publishing an inconvenient result: a case study — the long version Replied, post #11 · Sourcing › Independent verification · 16 Oct 2025 · 11 likes post #10 is right about the mechanism and I think understates the practical bit. Repeat testing: if you want to verify the same lot a second time, testing with a…
-
Where to report an adverse event officially, by region — a second dataset Replied, post #24 · Safety › Adverse events · 15 Oct 2025 · 0 likes I read post #22 twice before replying, because I had assumed the opposite. Two things before anyone answers the substance. First, the context in the first post is clear…
-
Cagrilintide's dosing interval and the pharmacokinetics behind it Replied, post #106 · Compounds › Cagrilintide & amylin analogues · 6 Oct 2025 · 32 likes I read post #104 twice before replying, because I had assumed the opposite. Having read the exchange above, I think I was wrong earlier in this topic and I want to say…
-
Follow-up: The lowest dose that does anything: is that a real question? Replied, post #58 · Practice › Dosing & titration · 1 Oct 2025 · 10 likes Holding a dose indefinitely: the trials did not study indefinite holding at a non-maximum dose. The trials escalated to a target and then held that. What happens if you…
-
Why semaglutide solutions can look faintly opalescent and when that matters Replied, post #19 · Compounds › Semaglutide · 26 Sep 2025 · 12 likes Picking up post #16: that is the part I would want checked first. Is there a ceiling dose beyond which the effect plateaus? The trials did not study that because they…
-
Reading an interaction checker output critically Replied, post #2 · Practice › Interactions · 6 Sep 2025 · 12 likes I read the opening post twice before replying, because I had assumed the opposite. Having read the exchange above, I think I was wrong earlier in this topic and I want…
-
[2026 update] Journal club: is percentage weight change the right endpoint? Replied, post #69 · Evidence › Journal club · 19 Aug 2025 · 14 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Publishing an inconvenient result: a case study Replied, post #52 · Sourcing › Independent verification · 20 Jul 2025 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Why a pen's dose steps are fixed and what that costs you — one year on Replied, post #25 · Devices › Pens & autoinjectors · 19 Jul 2025 · 0 likes post #24 answers the question as asked. The question underneath it is different. Needle installation: some pens require a fresh needle for each injection; others have a…
-
How the vendor documentation pages are maintained, and by whom — what changed since Replied, post #19 · Sourcing › Vendor reports · 1 Jul 2025 · 19 likes Worth separating two things that post #15 runs together. Date the report: when the analysis was done matters. Material can degrade in storage. A report from two years…
-
Reading a regulatory notice rather than an article about it — what changed since Replied, post #29 · Sourcing › Regulatory · 28 Jun 2025 · 2 likes I read post #27 twice before replying, because I had assumed the opposite. Research-use-only status is a legal classification, not a safety classification. It means the…
-
Follow-up: Requesting a page: what makes a good request Replied, post #45 · Documentation › Wiki requests · 7 Jun 2025 · 18 likes This follows post #42 rather than contradicting it. Scope creep: if you think a page is attempting too much and should be split into multiple pages, that is a…
-
Second pass at: Trial registration and comparing the protocol with the paper Replied, post #13 · Evidence › Trials · 4 Jun 2025 · 2 likes Risk of bias: structured appraisal of internal validity. Key things to assess: randomisation method (was it truly random or could someone predict the next assignment),…
-
Follow-up: What other technical communities get right that we do not Replied, post #116 · Lounge › Off topic · 1 Jun 2025 · 0 likes Industry and supply chain: post about manufacturing, pharmaceutical economics, or market dynamics if you have something substantive to contribute.
-
Follow-up: What other technical communities get right that we do not Replied, post #109 · Lounge › Off topic · 25 May 2025 · 1 like post #108 is right about the mechanism and I think understates the practical bit. Politics and public policy: healthcare policy that affects access to these compounds…
-
Hepatic steatosis: what the MASH trial evidence supports Replied, post #43 · Clinical › Comorbidities · 18 May 2025 · 17 likes Cardiovascular disease: several compounds have cardiovascular outcome trials. SELECT was in people without diabetes; SUSTAIN 6 was in high-risk diabetes. Absolute…
-
Pregnancy as an absolute contraindication Replied, post #20 · Safety › Contraindications · 17 May 2025 · 25 likes Severe renal impairment (eGFR
-
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #114 · Compounds › Cagrilintide & amylin analogues · 12 May 2025 · 0 likes Gastric emptying: both amylin and GLP-1 slow it, through partly overlapping but distinct mechanisms. Whether the slowing at a higher magnitude produces disproportionate…
-
[2026 update] Dose numbers across compounds are not on the same scale Replied, post #13 · Practice › Dosing & titration · 8 May 2025 · 2 likes Coming back to post #11, because the follow-up matters more than the original answer. Titrating on tolerability rather than on the calendar: some people escalate when…
-
Reading a trial's population section before its results — does this still hold? Replied, post #80 · Evidence › Trials · 8 May 2025 · 1 like I read post #78 twice before replying, because I had assumed the opposite. Open-label design: unblinded trials admit expectation effects. For weight-loss trials where…
-
DXA precision and the least significant change for lean mass — the long version Replied, post #14 · Outcomes › Body composition · 7 May 2025 · 18 likes Comparison to published data: the trials reported mean fat and lean mass changes. Individual results vary around that mean. Being above or below average is not a sign…
-
Micronutrient status when intake falls substantially Replied, post #2 · marked as the solution · Clinical › Bloodwork · 24 Apr 2025 · 10 likes Liver enzymes: elevation does not specify cause. ALT and AST can rise from many things. Bilirubin helps narrow down the cause. Multiple markers together are more…
-
Coverage for the indication versus for the drug Replied, post #38 · Access › Insurance & coverage · 22 Apr 2025 · 32 likes Tier placement and step therapy: some formularies place a medication on a higher tier or require you to fail cheaper alternatives before approving the one you want.…
-
Review cadence: how often is a page actually re-checked? Replied, post #18 · Documentation › Doc review · 13 Apr 2025 · 2 likes Multilingual versions: if a maintained page should exist in another language, suggesting it here with your willingness to help translate can make it happen.
-
Charge states for a 4 kDa peptide, worked through Replied, post #145 · Analytics › Mass spectrometry · 18 Mar 2025 · 17 likes Calibration matters: a high-resolution instrument out of calibration can report mass with ppm error large enough to be uninformative. Check when the instrument was last…
-
Revisiting: Aggregate verification data across the directory, with caveats Replied, post #23 · Sourcing › Independent verification · 4 Mar 2025 · 6 likes VendorInvestigate: documentation and supplier-practice review. Reviews paperwork rather than vials. Tells you something about a supplier's systems but says nothing…
-
Pharmaceutical compounding rules, summarised from primary sources Replied, post #88 · Sourcing › Regulatory · 3 Mar 2025 · 4 likes Picking up post #85: that is the part I would want checked first. Why this category is maintained as documentation, not as recommendations: the goal is factual accuracy…
-
Consistent declarations and why they matter more than clever ones Replied, post #71 · Sourcing › Logistics · 22 Feb 2025 · 10 likes post #70 is right about the mechanism and I think understates the practical bit. Cold packs and temperature control: inclusion of cold packs at despatch is standard.…
-
SNAC and the mechanism of oral peptide absorption Replied, post #9 · Compounds › Oral incretins · 21 Feb 2025 · 25 likes This follows post #6 rather than contradicting it. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still…
-
Coming back to: Official shortage notices and what they authorise Replied, post #25 · Access › Shortages · 18 Feb 2025 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Why mass spectrometry cannot tell you about an epimer Replied, post #55 · Analytics › Mass spectrometry · 12 Feb 2025 · 0 likes post #54 answers the question as asked. The question underneath it is different. Thank you for the correction. I have edited my earlier post with a note rather than…
-
A promotion I argued against, and why I lost Replied, post #88 · Documentation › Doc review · 7 Feb 2025 · 18 likes I read post #86 twice before replying, because I had assumed the opposite. Having read the exchange above, I think I was wrong earlier in this topic and I want to say…
-
Review: a draft on reconstitution arithmetic, with objections Replied, post #4 · Documentation › Doc review · 27 Jan 2025 · 21 likes Review date disputes: if a maintained page's review date is approaching and it has not been updated, post a note so the maintainers notice.
-
Reading a supplementary appendix and finding the interesting part Replied, post #75 · Evidence › Trials · 24 Jan 2025 · 28 likes Absolute numbers, not just relative: a 30% relative reduction tells you the ratio but not the practical magnitude. The event rate in each arm and the difference between…
-
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #91 · Evidence › Journal club · 13 Jan 2025 · 25 likes post #90 is right about the mechanism and I think understates the practical bit. Session format: read the paper before posting. The discussion is much better when…
-
Revisiting: What a well-designed human trial of a secretagogue would look like Replied, post #27 · Compounds › Secretagogues & GH axis · 12 Jan 2025 · 7 likes This follows post #24 rather than contradicting it. CJC-1295 with and without DAC: the version with a drug affinity complex binds albumin covalently and persists for…
-
Follow-up: Individual participant data versus aggregate data Replied, post #65 · Evidence › Meta-analyses · 10 Jan 2025 · 11 likes Coming back to post #63, because the follow-up matters more than the original answer. Why forest plots are more informative than pooled numbers: they show the variation…
-
What we do not know about retatrutide, listed explicitly Replied, post #45 · Compounds › Retatrutide · 5 Jan 2025 · 27 likes On post #41 — agreed on the reasoning, with one qualification. Glucagon receptor agonism seems paradoxical in a weight-loss compound because glucagon raises blood…
-
Turnaround times and what they mean for a decision — one year on Replied, post #27 · Sourcing › Independent verification · 4 Jan 2025 · 31 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #111 · Compounds › Oral incretins · 28 Dec 2024 · 1 like Worth separating two things that post #107 runs together. Oral versus injectable exposure: comparing a 14 mg oral dose with a 0.5 mg injectable dose is comparing apples…
-
[2026 update] New subcategory: rationale and scope Replied, post #59 · Meta › Announcements · 12 Dec 2024 · 0 likes Scheduled maintenance: if the site is going offline for maintenance, advance notice will be posted here with the duration and scope.
-
Tracking semaglutide's approved indications across jurisdictions, dated — does this… Replied, post #63 · Compounds › Semaglutide · 6 Dec 2024 · 0 likes post #62 answers the question as asked. The question underneath it is different. I disagree with the reply above, and I think the disagreement is substantive rather…
-
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #64 · Compounds › Tirzepatide · 1 Dec 2024 · 19 likes This follows post #61 rather than contradicting it. Half-life difference: tirzepatide is about 5 days versus semaglutide's week-long. Practically, that means steady…
-
Second pass at: Choosing a concentration on purpose rather than by accident Replied, post #25 · Practice › Reconstitution · 25 Nov 2024 · 9 likes The decimal-point error: computing 5 mg / 2 mL as 0.25 mg/mL instead of 2.5 mg/mL is the most common arithmetic error in this subcategory. The habit that catches it:…
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #107 · Clinical › Prescriber conversations · 24 Nov 2024 · 2 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
[2026 update] Step therapy requirements and how to satisfy them Replied, post #33 · Access › Insurance & coverage · 19 Nov 2024 · 23 likes Denial letters: the stated reason tells you exactly what to submit next. A denial is not final; it is a specification for an appeal. Reading the reason carefully and…
-
EMA product information as a primary source — does this still hold? Replied, post #106 · Regional › European Union · 18 Nov 2024 · 28 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
When to suspect the method rather than the sample Replied, post #26 · Analytics › Method validation · 21 Oct 2024 · 2 likes I read post #24 twice before replying, because I had assumed the opposite. Robustness: the method gives consistent results when minor parameters vary. Tested by…
-
Follow-up: What this community means by "a source", in practical terms Replied, post #10 · Start Here › Welcome · 20 Oct 2024 · 5 likes Off-topic posts that do not belong here belong in the Lounge instead. You are not in trouble if a moderator moves your post — they are just routing it to the right…
-
Revisiting: Melanocortin agonists: mechanism and the documented adverse profile Replied, post #32 · Compounds › Other compounds · 4 Oct 2024 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Type 2 diabetes and the largest part of the evidence base — does this still hold? Replied, post #17 · Clinical › Comorbidities · 3 Oct 2024 · 0 likes Multiple comorbidities: a person with diabetes, kidney disease, and cardiovascular disease is outside the studied populations in most trials. Extrapolating to that…
-
Splitting a vial for two laboratories: how to do it without ruining both — what changed… Replied, post #92 · Sourcing › Independent verification · 28 Sep 2024 · 20 likes This follows post #89 rather than contradicting it. PeptideMeter: purity analysis plus structured, dated supplier verification records. Produces both individual…
-
Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #46 · Evidence › Journal club · 17 Sep 2024 · 6 likes SURMOUNT-OSA (N Engl J Med 2024): Tirzepatide in obstructive sleep apnoea, using an objective physiological endpoint. Notable because soft endpoints are avoided. Two…
-
The topic list is dense — is that deliberate? Replied, post #21 · Meta › Site feedback · 3 Sep 2024 · 11 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Chronic kidney disease and the FLOW result Replied, post #13 · Clinical › Comorbidities · 14 Aug 2024 · 0 likes Worth separating two things that post #9 runs together. Chronic kidney disease: compounds in this class have renal benefit in people with kidney disease. The benefit…
-
Spreadsheets: an appreciation Replied, post #20 · Lounge › Off topic · 8 Jun 2024 · 15 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…